1.Bin Huang,Lei Guo, and Yanxing Jia*. “Protecting-group-free enantioselective synthesis of (–)-pallavicinin and (+)-neopallavicinin”.Angew. Chem., Int. Ed. 2015, 54, 13599. (IF = 12.102, Q1)
2.Bin Huang*, Jing Pang, Nan Cao, Ya-Shuang Dai,Ya-Qiu Long*. Concise asymmetric total syntheses of (+)-dihydropleurotinic acid and (-)-pleurotin, enabling rapid late-stage diversification. JACS Au, 2024, 4, 4206-4211. (IF = 8.5, Q1)
3.Jing Pang#, Shun Feng#, Bin Huang#, Jujun Zhou, Linjun Zhan, Ya-Qiu Long*. Novel Bioorthogonal Theranostic Scaffold Enables on-Target Drug Release and Real Time Monitoring In Vivo. J. Med. Chem.2025, 68, 3824. (IF = 6.8, Q1)
4.Heng Li#, Yexin Du#, Qiurong Li#, Junlei Zhang#, Jianping Zhao, Mengxin Niu, Shuying Su, Aocheng Xie, Wei He, Guiyan Huang, Lihua Xiao, Zhichao Huang, Ikhlas A. Khan, Shilin Yang, Suxiang Feng*, Bin Huang*, Qiongming Xu*, Yanli Liu*. Design and synthesis of anemoside B4 derivatives as pyruvate carboxylase-targeting therapeutic agents for atopic dermatitis. J. Med. Chem., 2026, DOI: 10.1021/acs.jmedchem.6c00451. (IF = 7.3, Q1)
5.Bin Huang,#, Z. Xu,#, D. Liao, Y. Zhang, M. Ruan, Z. Fan, W. Liu*, Ya-Qiu Long*. Synthesis and discovery of simplified pleurotin analogs bearing tricyclic core as novel thioredoxin reductase inhibitors. Eur. J. Med. Chem. 2025, 285, 117242. (IF = 6.0, Q1)
6.Guiyan Huang, Yu Lin, Jianping Zhao, Junlei Zhang, Yexin Du, Mingyue Xiao, Heng Li, Zhong Chen, Naixin Kang, Ikhlas A. Khan, Yanli Liu, Bin Huang*, Qiongming Xu*. Corosolic acid and its derivatives targeting MCCC1 against insulin resistance and their hypoglycemic effect on type 2 diabetic mice. Eur. J. Med. Chem., 2025, 284, 117184. (IF = 6.0, Q1)
7.Jing Pang, Nan Cao, Ya Shuang Dai, Xiaolei Huang, Yanli Liu, Bin Huang*, Ya Qiu Long*. Diversifiable Total Synthesis of Pleurotin Natural Products through Alternative Endgame Strategies Enabling Unprecedented C7/C8 Axial Functionalization. Org. Lett., 2025, 27, 11137. (IF = 5.0, Q1)
8.B. Huang#, F. Zhang#, G. Yu#, Y. Song, X. Wang, M. Wang, Z. Gong, R. Su, and Y. Jia*. “Gram scale syntheses of (-)-incarvillateine and its analogs, discovery of potent analgesics for neuropathic pain”.J. Med. Chem.,2016, 59, 3953. (IF = 6.259, Q1)
9.Li-Rui Song, He Li, Shen-Feng Wang, Jian-Ping Lin Bin Huang* and Ya-Qiu Long*. Metal-free hypervalent iodine-promoted tandem carbonyl migration and unactivated C(Ph)-C(Alkyl) bond cleavage for quinolone scaffold synthesis. Chem. Commun.2022, 58, 8340. (cover paper)(IF = 4.3, Q2)
10.B. Huang, R. Liffert, A. Linden, K. Gademann*. “Metal free regioselective chloroazidation of internal alkynes”.Chem. Eur. J. 2019, 25, 981. (IF = 5.160, Q2)
11.Bin Huang, Qingjiang Li. Rh-Catalyzed Regio- and Enantioselective Hydroboration of gem-Difluorinated Cyclobutenes. Chin. J. Org. Chem. 2024, 44, 2611. (IF = 2.2, Q3)
12.X. Zhang, B. Huang,and Y. Jia*. “Enantioselective total synthesis of pallabins A, B, C and D”.Angew. Chem., Int. Ed. 2019, 58, 13380. (IF = 12.102)
13.X. Bian, Y. Zhang, B. Huang, G. Wang, Y. Liu, X. Wang, J. Liang, Y. Jia*, K. Wang*.Natural product incarvillateine inhibits GABAA receptor currents.Eur. J. Pharmacol. 2019, 858, 172496. (IF = 2.896)
14.M. Wang, G. Yu, S. Yi, F. Zhang, B. Huang, Z. Wang, R. Su, Y. Jia*, Z. Gong*. “The antinociceptive effects of incarvillateine, a monoterpene alkaloid from incarvillea sinensis, and possible involvement of adenosine system”. Sci. Rep.2015, 5, 16107.(IF = 4.122)
15.F. Zhang, B. Wang, B. Huang, Y. Jia*. “The preparation methods and analgesic effects of incarvillateine and analogs”. CN 201110254018.0(2011) (in Chinese).
16.L. Shi, L. Li, J. Wang, B. Huang, K. Zeng, H. Jin, Q. Zhang, Y. Jia*. Total synthesis of natural spiro-trisindole enantiomers similisines A, B and their stereoisomers.Tetrahedron Lett. 2017, 58, 1934. (IF = 2.379)
17.Shuang Yang, Xiao-Bin Liu, Si-Xin Feng, Yin Li, Fang-Hai Tu, Bin Huang, Long-Ling Huang, Zhi-Shu Huang, Honggen Wang* and Qingjiang Li*. Hypervalent iodine(III)-mediated ring-expansive difluorination of alkynylcyclopropanes en route to the synthesis of difluorinated alkylidenecyclobutanes. Org. Chem. Front., 2022, 9, 4447. (IF = 4.6)